Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Heather Lynn Del Buono"'
Autor:
Karl D. Lewis, Nageatte Ibrahim, Igor Puzanov, Kevin B. Kim, Georgina V. Long, D.P. Lawrence, Omid Hamid, Adil Daud, Elizabeth Cunningham, Gerald Steven Falchook, Howard A. Burris, Keith T. Flaherty, Alain Algazi, Lynn M. Schuchter, Jonathan Cebon, Heather Lynn Del Buono, Amy S. Kline, Jeffrey R. Infante, Kiran Patel, Jeffrey S. Weber, Ragini Kudchadkar, Rene Gonzalez, Diane Opatt McDowell, Richard F. Kefford, Peng Sun, Jeffrey A. Sosman
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 34(8)
Purpose To report the overall survival (OS) and clinical characteristics of BRAF inhibitor–naive long-term responders and survivors treated with dabrafenib plus trametinib in a phase I and II study of patients with BRAF V600 mutation–positive met
Autor:
Heather Lynn Del Buono, Girishanthy Krishnarajah, K. Annunziata, Marco DiBonaventura, Aaron Rak
Publikováno v:
PLoS ONE, Vol 7, Iss 11, p e50553 (2012)
PLoS ONE
PLoS ONE
BACKGROUND: In order to adequately assess the effectiveness of vaccination in helping to control vaccine-preventable infectious disease, it is important to identify the adherence and uptake of risk-based recommendations. METHODS: The current project
Autor:
Keith T. Flaherty, Peng Sun, Lynn M. Schuchter, Kevin Kim, Rene Gonzalez, Amy S. Kline, Donald P. Lawrence, Jeffrey S. Weber, Omid Hamid, Jeffrey A. Sosman, Jonathan Cebon, Alain Algazi, Heather Lynn Del Buono, Georgina V. Long, Diane Opatt McDowell, Igor Puzanov, Ragini Kudchadkar, Adil Daud, Richard F. Kefford, Jeffrey R. Infante
Publikováno v:
Journal of Clinical Oncology. 33:9036-9036
9036 Background: This Phase I—II study evaluated the safety and efficacy of the combination of dabrafenib and trametinib (the combination) compared with dabrafenib alone (monotherapy) in patients (...
Autor:
Linda P. Briley, Karen S. King, Diptee A. Kulkarni, Jeffrey J. Legos, C. Dabrowski, Heather Lynn Del Buono, Bijoyesh Mookerjee, Colin F. Spraggs, Kijoung Song
Publikováno v:
Journal of Clinical Oncology. 33:e20026-e20026
e20026 Background: Dabrafenib (D) and trametinib (T) single agents have superior efficacy compared with chemotherapy in metastatic melanoma with BRAF V600E/K mutation, and their use in combination ...